Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-060083
Filing Date
2018-11-27
Accepted
2018-11-27 21:11:00
Documents
1
Period of Report
2018-11-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2653
  Complete submission text file 0001209191-18-060083.txt   3996
Mailing Address 3204 BEVERLY DRIVE DALLAS TX 75205
Business Address
MAULDIN JOHN F (Reporting) CIK: 0001522480 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38519 | Film No.: 181204054

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-521-3390
AgeX Therapeutics, Inc. (Issuer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations